8-K
Current Report
Liminatus Pharma, Inc. Filed Acc 0001104659-25-067444
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading tm2520692d1_8k.htm…